Hemostemix's 4th Heart Study Published in Stem Cell Research

Hemostemix Inc. is pleased to announce that Stem Cell Research & Therapy published the Company's seventh peer reviewed study of ACP-01 - the third peer reviewed study of ACP-01 as a treatment for...

Related Keywords

United States , Thomas Smeenk , Venture Exchange , Regulation Service Provider , Stem Cell Research Therapy , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Alberta Newsfile Corp , Stem Cell Research , United Statesa , Markets ,